José Federico
Díaz González
Catedrático de Universidad
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital General Universitario Gregorio Marañón (14)
2024
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
-
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598
2023
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Advances in Rheumatology, Vol. 63, Núm. 1
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
2022
-
The reality of Rheumatology in Spain and its autonomous communities before the pandemic
Reumatologia Clinica, Vol. 18, Núm. 8, pp. 486-489
2021
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2017
-
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202
2015
2010
-
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68